Pallavi Parashar
Contact
Clinical Professor, Faculty of Medicine & Dentistry - Dentistry Dept
- pparasha@ualberta.ca
- Phone
- (780) 248-1119
- Address
-
5391 Dianne and Irving Kipnes Health Research Academy
11405 87 Ave NWEdmonton ABT6G 1C9
Overview
Area of Study / Keywords
About
Dr. Pallavi Parashar is a board certified Oral and Maxillofacial Pathologist. She received her Dental Degree in India, after which she completed a residency program in Oral and Maxillofacial Pathology at University of Maryland, Baltimore. She was awarded a DDS degree at University of Colorado after she completed the Advanced Standing Program for International Dentists.
Dr. Parashar currently co-directs the Oral Medicine Graduate Program at the University of Alberta. She specializes in Clinical and Microscopic diagnosis of Oral Pathology. She is passionate about her profession and is actively involved in research activities.
Courses
DENT 615 - Oral Medicine Clinics V
Guided clinical experience in the assessment and evidence-based management of oral lesions or oral manifestations of systemic diseases for a second year student. Prerequisite: DENT 614.
Featured Publications
Abrol N., Compton S.M., Graf D., Parashar P., Heo G., Gibson M.P.
lin Exp Dent Res . . 2022 June; 10.1002/cre2.609
Bilateral Parotid Sialoliths in a Patient Diagnosed with Sjögren Syndrome: Role of 2-D Conventional Radiographs.
AAOM 2022. 2022 May;
Perez Rosero E., Heron S., Jovel J., O’Neil C.R., Turvey S.L., Parashar P., Elahi S.
Frontiers in Immunology. 2021 November; 12 10.3389/fimmu.2021.780910
Giant Asymptomatic Sialolith in the Submandibular Duct: A Case Report
Annual Meeting American Academy of Oral Medicine. 2021 April;
Mucocutaneous Manifestations of Cowden Syndrome: Role of an Oral Diagnostician
Annual meeting American Academy of Oral Medicine. 2021 April;
Primary Oral Mucosal Melanoma Mimicking An Amalgam Tattoo: Diagnostic Pitfalls
Annual meeting American Academy of Oral Medicine. 2021 April;
Okoye I., Xu L., Motamedi M., Parashar P., Walker J.W., Elahi S.
Journal for ImmunoTherapy of Cancer. 2020 December; 8 (2) 10.1136/jitc-2020-001849